Skip to main content

Advertisement

SpringerLink
Log in

The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation

  • Brief Communication
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

There is mounting evidence, derived from mechanistic studies, RCTs, and other high-quality studies that there are weight loss independent antidiabetic effects of gastrointestinal surgery. Additionally, there appears to be no relation between the positive metabolic outcomes to baseline BMI. The outdated US National Health Institutes guidelines from 1991 were centered on BMI only criterion and often misleading. The Second Diabetes Surgery Summit held in collaboration with leading diabetes organizations and endorsed by a large group of international Professional Societies developed guidelines that defined eligibility based on the severity and degree of T2D medical control while referring to obesity as a qualifier and not the sole criterion. That is the first time that guidelines are provided to put metabolic surgery into the T2D treatment algorithms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.

  2. Rubino F, Kaplan LM, Schauer PR, et al. The diabetes surgery summit consensus conference. Ann Surg. 2010;251(3):399–405.

    Article  PubMed  Google Scholar 

  3. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.

    Article  PubMed  Google Scholar 

  4. Gloy VL, Briel M, Bhatt DL, et al. BMJ. 2013;347:f5934. doi:10.1136/bmj.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study Randomized Clinical Trial Roux-en-Y Gastric Bypass and Diabetes. JAMA. 2013;309(21):2240–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.

    Article  PubMed  Google Scholar 

  7. Rubino F, Nathan D, Eckel RH, Schauer P, Alberti G, Zimmet P et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016.

  8. Cummings D, Cohen R. Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol. 2014;2(2):175–81.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Rubino F, Cummings DE. Surgery: the coming of age of metabolic surgery. Nat Med. 2012;8(12):1–3.

    Google Scholar 

  10. Müller-Stich BP, Senft JD, Warschkow R, et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients. Ann Surg. 2015;261(3):421–9.

    Article  PubMed  Google Scholar 

  11. Cohen R, Pinheiro JS, Correa JL, Schiavon CA. Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach 2006;2(3):401–4.

  12. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA: J Am Med Assoc. 2012;307(1):56–65.

    Article  Google Scholar 

  13. Cummings D & Cohen R - Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients with a BMI Less Than 35 kg/m2. Diabetes Care. 2016.

  14. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–37.

    PubMed  PubMed Central  Google Scholar 

  17. Chiu M, Austin PC, Manuel DG, et al. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011;34:1741–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity (Silver Spring). 2009;18(5):865–71.

    Article  Google Scholar 

  19. Tomiyama AJ, Hunger JM, Nguyen-Cuu J, Wells C. Int J Obes. 2016;1–15. doi:10.1038/ijo.2016.17.

  20. Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36(8):2271–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Keating C, Neovius M, Sjöholm K, et al. Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2015;3(11):855–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, Sao Paulo, SP, Brazil

    Ricardo V. Cohen, Tarissa Petry & Pedro Paulo Caravatto

  2. Center for Metabolic and Bariatric Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Scott Shikora

  3. Diabetes Complication Research Centre, UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland

    Carel W Le Roux

Authors
  1. Ricardo V. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Shikora
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tarissa Petry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pedro Paulo Caravatto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carel W Le Roux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ricardo V. Cohen.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cohen, R.V., Shikora, S., Petry, T. et al. The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation. OBES SURG 26, 1989–1991 (2016). https://doi.org/10.1007/s11695-016-2237-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-016-2237-6

Keywords

Search

Navigation